Evidence map›Paper›PMID 35527820›Full record

ArticleFrontiers in neuroscience2022

Control of Behavioral Arousal and Defense by a Glutamatergic Midbrain-Amygdala Pathway in Mice.

Shang-Yi Chen, Jing Yao, Yu-Duan Hu, Hui-Yun Chen, Pei-Chang Liu, Wen-Feng Wang, Yu-Hang Zeng, Cong-Wen Zhuang, Shun-Xing Zeng, Yue-Ping Li and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Dorsal Raphe VIP Neurons Are Critical for Survival-Oriented Vigilance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The Formation and Function of the VTA Dopamine System.International journal of molecular sciences · 2024
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Shang-Yi ChenDepartment of Epidemiology and Health Statistics, The School of Public Health, Fujian Medical University, Fuzhou, China.
Jing YaoFujian Province Key Laboratory of Environment and Health, The School of Public Health, Fujian Medical University, Fuzhou, China.
Yu-Duan HuDepartment of Epidemiology and Health Statistics, The School of Public Health, Fujian Medical University, Fuzhou, China.
Hui-Yun ChenFujian Province Key Laboratory of Environment and Health, The School of Public Health, Fujian Medical University, Fuzhou, China.
Pei-Chang LiuDepartment of Anesthesiology, Fujian Medical University Union Hospital, Fuzhou, China.
Wen-Feng WangSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Yu-Hang ZengSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Cong-Wen ZhuangSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Shun-Xing ZengSchool of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Yue-Ping LiSchool of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Liu-Yun YangSchool of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Zi-Xuan HuangSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Kai-Qi HuangSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Zhen-Ting LaiSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Yong-Huai HuSchool of Basic Medicine, Fujian Medical University, Fuzhou, China.
Ping CaiFujian Province Key Laboratory of Environment and Health, The School of Public Health, Fujian Medical University, Fuzhou, China.
Li ChenDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, China.
Siying WuDepartment of Epidemiology and Health Statistics, The School of Public Health, Fujian Medical University, Fuzhou, China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In response to external threatening signals, animals evolve a series of defensive behaviors that depend on heightened arousal. It is believed that arousal and defensive behaviors are coordinately regulated by specific neurocircuits in the central nervous system. The ventral tegmental area (VTA) is a key structure located in the ventral midbrain of mice. The activity of VTA glutamatergic neurons has recently been shown to be closely related to sleep-wake behavior. However, the specific role of VTA glutamatergic neurons in sleep-wake regulation, associated physiological functions, and underlying neural circuits remain unclear. In the current study, using an optogenetic approach and synchronous polysomnographic recording, we demonstrated that selective activation of VTA glutamatergic neurons induced immediate transition from sleep to wakefulness and obviously increased the amount of wakefulness in mice. Furthermore, optogenetic activation of VTA glutamatergic neurons induced multiple defensive behaviors, including burrowing, fleeing, avoidance and hiding. Finally, viral-mediated anterograde activation revealed that projections from the VTA to the central nucleus of the amygdala (CeA) mediated the wake- and defense-promoting effects of VTA glutamatergic neurons. Collectively, our results illustrate that the glutamatergic VTA is a key neural substrate regulating wakefulness and defensive behaviors that controls these behaviors through its projection into the CeA. We further discuss the possibility that the glutamatergic VTA-CeA pathway may be involved in psychiatric diseases featuring with excessive defense.

Indexed as

autism spectrum disorderscentral nucleus of the amygdaladefensive behaviorsleep-wake behaviorventral tegmental area

Identifiers

PMID35527820
PMCPMC9070111
OpenAlexW4223977331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.